Menu
Emily Arsenault, CPA, MBA, joined ImmPACT Bio in March 2022 and serves as Vice President of Finance. Emily has spent the majority of her career supporting early and growth stage life sciences companies, most recently as Executive Director, Head of Finance and Operations at Plexium in San Diego, CA. Previously she served as Director, Finance and Controller at Mirati Therapeutics (NASDAQ: MRTX), a publicly traded oncology company based in San Diego, CA. Emily received her Bachelor of Arts and Master of Business degrees from San Diego State University and is a Certified Public Accountant in the state of California.
You are about to leave Immpact Bio's website to an external website.
Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.
You are about to leave Immpact Bio's website to an external website.
Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.
You are about to leave Immpact Bio's website to an external website.
Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.
You are about to leave Immpact Bio's website to an external website.
Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.
ImmPACT Bio is now part of Lyell Immunopharma
If you have a question about a clinical trial, please contact us at info@immpact-bio.com
